Effects of riluzole on electrically evoked neurotransmitter release

British Journal of Pharmacology

Volumn 130, Issue 6, 2000, Pages 1227-1234

  Jehle, T ^a   Bauer, J ^a   Blauth, E ^a   Hummel, A ^a   Darstein, M ^a   Freiman, T M ^a   Feuerstein, T J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Human; Mouse neocortex; Neurotransmitter release; Rat; Riluzole; Superfusion

Indexed keywords

AMPA RECEPTOR ANTAGONIST; DIZOCILPINE; DOPAMINE; GLUTAMIC ACID; GLUTAMINE; NEUROPROTECTIVE AGENT; NEUROTRANSMITTER; RILUZOLE; SEROTONIN; TRITIUM;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; ISOTOPE LABELING; MOUSE; NEOCORTEX; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033913617     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703424     Document Type: Article

References (40)

1. BARNEOUD, P., MAZADIER, M., MIQUET, J.M., PARMENTIER, S. & DUBEDAT, P. (1996). Neuroprotective effects of riluzole on a model of Parkinson's disease in the rat. Neuroscience, 74, 971-983.
2. BENAVIDES, J., CAMELIN, J.C., MITRANI, N., FLAMAND, F. & UZAN, A. (1985) 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission. Biochemical properties. Neuropharmacology, 24, 1085-1092.
3. BENOIT, E. & ESCANDE, D. (1991). Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre. Pflügers Arch., 419, 603-609.
4. BENSIMON, G., LACOMBLEZ, L. & MEININGER, V. (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N. Engl. J. Med., 330, 585-591.
5. BOIREAU, A., MEUNIER, M. & IMPERATO, A. (1998). Ouabaininduced increase in dopamine release from mouse striatal slices is antagonized by riluzole. J. Pharm. Pharmacol., 50, 1293-1297.
6. BRADFORD, H.F., WARD, H.K. & THOMAS, A.J. (1978). Glutamine -a major substrate for nerve endings. J. Neurochem., 30, 1453-1459.
7. CHERAMY, A., BARBEITO, L., GODEHEU, G. & GLOWINSKI, J. (1992). Riluzole inhibits the release of Glu in the caudate nucleus of the cat in vivo. Neurosci. Lett., 147, 209-212.
8. CHERAMY, A , ROMO, R., GODEHEU, G., BARUCH, P. & GLOWINSKI, J. (1986). In vivo presynaptic control of DA release in the cat caudate nucleus-II. Facilitatory or inhibitory influence of L-Glu. Neuroscience, 19, 1081-1090.
9. DEBONO, M.W., LE, G.J., CANTON, T., DOBLE, A. & PRADIER, L. (1993). Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur. J. Pharmacol., 235, 283-289.
10. DOBLE, A. (1996). The pharmacology and mechanism of action of riluzole. Neurology, 47, 233-241.
11. 3H]-aspartate release from cultured cerebellar granule cells. Neurosci. Lett., 140, 251-254.
12. ESTEVEZ, A.G., STRUTZMANN, J.M. & BARBEITO, L. (1995). Protective effect of riluzole on excitatory amino acid-mediated neurotoxicity in motoneuron-enriched cultures. Eur. J. Pharmacol., 280, 47-53.
13. 1-Opioid receptor-mediated control of acetylcholine (ACh) release in human neocortex slices. Int. J. Dev. Neurosci., 16, 795-802.
14. FEUERSTEIN, T.J. & LIMBERGER, N. (1999). Mathematical analysis of the control of neurotransmitter release by presynaptic receptors as a supplement to experimental data. Naunyn-Schmiedeberg's Arch. Pharmacol., 359, 349-359.
15. GODEL, H., GRASER, T., FOLDI, P., PFAENDER, P., & FURST, P. (1984). Measurement of free amino acids in human biological fluids by high-performance liquid chromotography. J. Chromatogr., 297, 49-61.
16. GRASER, T.A., GODEL, H.G., ALBERS, S., FOLDI, P. & FURST, P. (1985). An ultra rapid and sensitive high-performance liquid Chromatographic method for determination of tissue and plasma free amino acids. Anal. Biochem., 151, 142-152.
17. HUANG, C.S., SONG, J.H., NAGATA, K., YEH, J.Z. & NARAHASHI, T. (1997). Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J. Pharmacol. Exp. Ther., 282, 1280-1290.
18. HUBERT, J.P., DELUMEAU, J.C., GLOWINSKI, J., PREMONT, J. & DOBLE, A. (1994). Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br. J. Pharmacol., 113, 261-267.
19. HUGON, J. (1996). ALS therapy: targets for the future. Neurology, 47, 251-254.
20. KEITA, H., LEPOUSE, C., HENZEL, D., DESMONTS, J.M. & MANTZ, J. (1997). Riluzole blocks DA release evoked by N-methyl-D-aspartate, kainate, and veratridine in the rat striatum. Anesthesiology, 87, 1164-1171.
21. LACOMBLEZ, L., BENSIMON, G., LEIGH, P.N., GUILLET, P. & POWE, L. (1996). A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology, 47, 242-250.
22. LAGREZE, W.A., OTTO, T. & FEUERSTEIN, T.J. (1999). Neuroprotection in ischemia of the retina in an animal model. Ophthalmology, 96, 370-374.
23. LEIGH, P.N. & MELDRUM, B.S. (1996). Excitotoxicity in ALS. Neurology. 47, 221-227.
24. LINGAMANENI, R. & HEMMINGS JR H.C. (1999). Effects of anticonvulsants on veratridine-and KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci. Lett., 276, 127-130.
25. LUPP, A , LÜCKING, C.H., KOCH, R., JACKISCH, R. & FEUERSTEIN, T.J. (1992). Inhibitory effects of the antiparkinsonian drugs memantine and amantadine on N-methyl-D-aspartate-evoked acetylcholine release in rabbit caudate nucleus in vitro. J. Pharmacol. Exp. Ther., 263, 717-724.
26. MACIVER, M.B., AMAGASU, S.M., MIKULEC, A.A. & MONROE, F.A. (1996). Riluzole anesthesia: use-dependent block of presynaptic Glu fibers. Anesthesiology, 85, 626-634.
27. MALGOURIS, C., BARDOT, F., DANIEL, M., PELLIS, F. & RATAUD, J. (1989). Riluzole, a novel antiGlu, prevents memory loss and hippocampal neuronal damage in ischemic gerbils. J. Neurosci. 9, 3720-3727.
28. MARTIN, D., THOMPSON, M.A. & NADLER, J.V. (1993). The neuroprotective agent riluzole inhibits release of Glu and aspartate from slices of hippocampal area CA1. Eur. J. Pharmacol, 250, 473-476.
29. MARY, V., WAHL, F. & STUTZMANN, J.M. (1995). Effect of riluzole on quinolinate-induced neuronal damage in rats: comparison with blockers of Glurgic neurotransmission. Neurosci. Lett., 201, 92-96.
30. OBRENOVITCH, T.P. & URENJAK, J. (1998). Glu release inhibitors: a critical assessment of their action mechanism. Amino Acids, 14, 143-150.
31. PRATT, J., RATAUD, J., BARDOT, F., ROUX, M. & BLANCHARD, J.C. (1992). Neuroprotective actions of riluzole in rodent models of global and focal cerebral ischaemia. Neurosci. Lett., 140, 225-230.
32. REUBI, J.C. (1980). Comparative study of the release of Glu and GABA, newly synthesized from glutamine, in various regions of the central nervous system. Neuroscience, 5, 2145-2150.
33. RICHARDSON, I.W & SZERB, J.C. (1974). The release of labelled acetylcholine and choline from cerebral cortical slices stimulated electrically. Br. J. Pharmacol., 52, 499-507.
34. ROTHSTEIN, J.D. & KUNCL, R.W. (1995). Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J. Neurochem., 65, 643-651.
35. SINGER, E.A. (1988). Transmitter release from brain slices elicited by single pulses: a powerful method to study presynaptic mechanisms. Trends Pharmacol. Sci., 8, 274-276.
36. SZATKOWSKI, M., BARBOUR, B. & ATTWELL, D. (1990). Nonvesicular release of Glu from glial cells by reversed electrogenic Glu uptake. Nature, 348, 443-446.
37. TIMMERMAN, W. & WESTERINK, B.H. (1997). Brain microdialysis of GABA and Glu: what does it signify? Synapse, 27, 242-261.
38. WALDMEIER, P.C., WICKI, P. & FELDTRAUER, J.J. (1993). Release of endogenous Glu from rat cortical slices in presence of the Glu uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid. Naunyn-Schmiedeberg's Arch. Pharmacol, 348, 478-485.
39. YOKOO, H., SHIRAISHI, S., KOBAYASHI, H., YANAGITA, T., YAMAMOTO, R. & WADA, A. (1998). Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells. Naunyn-Schmiedeberg's Arch. Pharmacol, 357, 526-531.
40. ZONA, C., SINISCALCHI, A., MERCURI, N.B. & BERNARDI, G. (1998). Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons. Neuroscience. 85, 931-938.